Comcast announces a major restructuring of its connectivity division, appointing a new CEO, as it navigates a $240 million patent loss and gears up for a pivotal sports streaming season with the Olympics and Super Bowl on the horizon.
Despite a modest price target reduction, Morgan Stanley reaffirms its Overweight rating on Wingstop, citing the chicken wing chain's robust unit expansion and system-wide sales momentum as key drivers for its 2026 outlook.
Analyst Piper Sandler has lowered its price target on Black Diamond Therapeutics (BDTX) while maintaining an Overweight rating, following a broad review of its biotech coverage. The adjustment comes even as the company recently reported encouraging Phase 2 data for its lead oncology drug candidate.
Barclays initiates coverage with an Overweight rating and $20 price target on Altimmune, citing strong fundamentals and pipeline potential. The biotech firm prepares to channel recent offering proceeds toward its pivotal Phase 3 development for metabolic liver disease treatment pemvidutide.
Aptiv PLC sees mixed but upwardly revised price targets from major analysts, with Piper Sandler upgrading the auto tech supplier to Overweight and naming it a top pick for 2026, citing its pragmatic strategy and attractive valuation.
Barclays initiates coverage of 4D Molecular Therapeutics with an Overweight rating and a $33 price target, citing a favorable industry backdrop with potential M&A tailwinds and shifting focus away from drug pricing pressures. The gene therapy developer also outlined key clinical milestones expected through 2026.
Canadian junior miner G2 Goldfields Inc. (TSX: GTWO), despite recent losses, is projected by analysts to reach profitability within two years, backed by aggressive growth forecasts and a debt-free balance sheet.
With Warren Buffett's retirement, Berkshire Hathaway faces its most significant leadership transition. Yet, under new CEO Greg Abel, strategic portfolio shifts and a colossal war chest are fueling analyst optimism for the conglomerate's next chapter.
Nomura Holdings is implementing stricter risk controls at its digital asset subsidiary, Laser Digital, following significant crypto-related losses that contributed to a nearly 10% drop in its fiscal third-quarter profit, the firm's CEO confirmed.
As Bitcoin and major altcoins extend losses, the native token of decentralized exchange Hyperliquid has surged over 40% in a week, with its novel permissionless markets hitting record volumes, prompting some to label it a rare 'defensive' crypto asset.
Bitcoin staged a tentative recovery Monday, clawing back some losses after a volatile weekend saw prices plunge 11%. Analysts point to the return of institutional and ETF activity, though broader market headwinds from geopolitics to potential Fed policy shifts continue to cloud the outlook.
Tron founder Justin Sun announces plans to acquire up to $100 million in Bitcoin as prices dip below $77,000, contrasting with corporate treasury losses and broader market caution.
Investment firm Giverny Capital Asset Management reduced its stake in industrial manufacturer AMETEK in Q4 2025, highlighting a disciplined approach to valuation as markets remain captivated by AI narratives. The firm's portfolio underperformed major indices, pressured by its underweight stance in mega-cap technology.
Analysts at Piper Sandler have increased their price target for Permian Basin-focused producer Diamondback Energy (FANG) to $218, maintaining an Overweight rating. The move comes as the firm anticipates solid Q4 results for gas-focused companies, while oil producers navigate a tougher pricing environment.
Auna S.A. (NYSE:AUNA) saw its market value shed $55 million last week, with its largest shareholder group—private equity firms—absorbing the heaviest losses. We analyze the ownership structure and what it means for the Latin American healthcare provider's future.
While Vidhance (FRA:8W50) continues to operate at a loss, its current cash reserves and manageable burn rate suggest the company has time to execute its growth strategy. However, a recent dip in revenue adds a note of caution for investors.
Under Armour faces a pivotal moment as a significant insider purchase coincides with a high-stakes legal loss and the exit of its Chief Product Officer, testing investor confidence in the embattled sportswear brand's turnaround strategy.
The refiner's journey from losses to profitability, marked by a rising Return on Capital Employed (ROCE), is drawing investor attention. While its 5.1% ROCE still lags the industry, the positive trajectory suggests strategic reinvestment is paying off.
TreeHouse Foods (THS) shares have rebounded sharply over the past three months, gaining 31%, even as the company reports significant annual losses. This divergence between short-term momentum and long-term fundamentals is prompting a fresh debate on valuation and the path to profitability for the private-label food manufacturer.
Japan's financial giant Nomura Holdings is scaling back risk at its digital asset unit following Q3 losses, a strategic pullback that mirrors wider pain across the crypto treasury sector as Bitcoin struggles to hold key levels.
